Hormone replacement use, arterial distensibility, cardiac structure and circadian blood pressure profile in menopausal women

References

• Yosefy C, Dicker D, Viskoper JR, et al. The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality. Prey Med. 2003;37(6 Pt 1):571–6.
   Google Scholar
• Flack JM, Casciano R, Casciano J, et al. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface. 2002;15:28–36.
   PubMedGoogle Scholar
• Bush TL, Barrett-Connor E, Cowan LD, et al. Cardio-vascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102–9.
   PubMed Web of Science ®Google Scholar
• Scuteri A, Lakatta EG, Bos AJG, Fleg JL. Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women. Aging Clin Exp Res. 2001;13:122–30.
   Google Scholar
• Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786–91.
   Google Scholar
• Lieberman EH, Gerhard MD, Uehara A, et al. Estrogen improves endothelium-dependent flow mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936–41.
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen-progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JANIA. 2002;288:321–33.
   Google Scholar
• Manson J, Hsia J, Johson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523–34.
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Furberg C, Herrington D, Riggs B, Vittingh E, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention in postmenopausal women. JAMA. 1998;280:605–13.
   Google Scholar
• Grodstein F, Manson J, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of post-menopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133:933–41.
   PubMed Web of Science ®Google Scholar
• Miura S, Tanaka E, Mori A, et al. Hormone replacement therapy improves arterial stiffness in normotensive post-menopausal women. Maturitas. 2003;45:293–8.
   PubMed Web of Science ®Google Scholar
• De Meersman RE, Zion AS, Giardina EGV, Weir JP, Lieberman JS, Downey JA. Estrogen replacement, vasculardistensibility, and blood pressures in postmenopausal women. Am J Physiol. 1998;274:H1539–44.
   Google Scholar
• Westendorp ICD, de Kleijn Mll, Bots ML, et al. The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial. Atherosclerosis. 2000;152:149–57.
   PubMedGoogle Scholar
• Gorgulu S, Eren M, Celik S, et al. The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function. Acta Cardiol. 2003;58:1–8.
   Web of Science ®Google Scholar
• Lim WK, Wren B, Jepson N, Roy S, Caplan G. Effect of hormone replacement therapy on left ventricular hypertrophy. Am J Cardiol. 1999;83:1132-4, A9.
   Google Scholar
• Light KC, Hindlerliter AL, West SG, et al. Hormone replacement improves homodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women. J Hypertens. 2001;19:269–78.
   PubMed Web of Science ®Google Scholar
• Sites C, Tischler MD, Blackman JA, et al. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril. 1999;71:137–43.
   PubMed Web of Science ®Google Scholar
• Snabes MC, Payne JP, Kopelen HA, Dunn JK, Young RL, Zoghbi WA. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo controlled, crossover trial. Obstet Gynecol. 1997;89:332–9.
   PubMed Web of Science ®Google Scholar
• Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-hour blood pressure profile of postmenopau-sal women. Am J Hypertens. 2000;13: 1039–41.
   Google Scholar
• Mercuro G, Zoncu S, Piano D, et al. Estradio1-17 beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmeno-pausal hypertension. Am J Hypertens. 1998;11(8 Pt 1):909–13.
   Google Scholar
• Mills PJ, Farag NH, Matthews S, Nelesen RA, Berry CC, Dimsdale JE. Hormone replacement therapy does not affect 24-h ambulatory blood pressure in healthy non-smoking postmenopausal women. Blood Press Monit. 2003;8:57–61.
   PubMed Web of Science ®Google Scholar
• Handa SP, Wong J, Wolf HK. The relationship of plasma norepinephrine levels and aortic distensibility in elderly with isolated systolic hypertension. Am J Hypertens. 1995;8:422–5.
   Google Scholar
• Stefandis C, Stratos C, Bourdoulos H, Kourouklis C, Toutoyzas P. Distensibility of the ascending aorta: compar-ison of invasive and noninvasive techniques in healthy men and in men with coronary artery disease. Eur Heart J. 1990;11:990–6.
   Google Scholar
• Devereux RB, Reichek N. Left ventricular hypertrophy. Cardiovasc Res. 1980;1:55–61.
   Google Scholar
• Pierdomenico SD, Bucci A, Constantini F, et al. Circadian blood change changes and myocardial ischemia in hyperten-sive patients with coronary artery disease. J Am Coll Cardiol. 1998;32:1627–34.
   Google Scholar
• Verdechhia P, Schillaci G, Borgioni C, et al. Altered circadian blood pressure profile and prognosis. Blood Press Monit. 1997;2:347–52.
   Google Scholar
• Rajkumar C, Kingwell BA, Cameron J, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol. 1997;30:350–6.
   PubMed Web of Science ®Google Scholar
• Sites CK, Tischler MD, Blackman JA, et al. Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril. 1991;71: 137–43.
   Google Scholar
• Hayward CS, Samarask K, Campbell L, Kelly RP. Effect of combination of hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women. Am J Hypertens. 2001; 14(7 Pt 1):699–703.
   Google Scholar
• Akkada AA, Halligan AW, Abrams K, al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol. 1997;89: 97–103.
   Google Scholar
• Manhem K, Ahlm H, Milsom I, Svebsson A. Transdermal oestrogen reduces daytime blood pressure in hypertensive women. J Human Hypertens. 1998;12:323–7.
   PubMed Web of Science ®Google Scholar
• Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO 3rd, Quyyumi AA, Panza JA. Effect of cooper-zinc superoxide dis-mutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertens. 1995;26:863–8.
   Google Scholar
• Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab. 2000;85:1577–83.
   Google Scholar
• Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers. A J Epidemiol. 1996;143:971–8.
   Google Scholar
• Egeland GM, Kuller LH, Matthews KA, Kelsey SF, Cauley J, Guzick D. Premenopausal determinants of menopausal estrogen use. Preventive Medicine. 1991;20:343–9.
   PubMed Web of Science ®Google Scholar
• Dallongeville J, Marceaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis. 1995;118:123–33.
   PubMed Web of Science ®Google Scholar
• Lip GY, Beevers M, Churchill D, Beevers DG. Hormone replacement therapy and blood pressure in hypertensive women. J Human Hypertens. 1994;8:491–4.
   PubMed Web of Science ®Google Scholar
• Czarnecka D, Kawecka-Jaszoz K, Olszanecka A, et al. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. Med Sci Monit. 2004;10:CR55–61.
   Google Scholar
• Safar ME. Pulse pressure in essential hypertension: clinical and therapeutic implications. J Hypertens. 1989;7:769–76.
   PubMedGoogle Scholar
• Cacciatore B, Paakkari I, Hasselblatt R, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol. 2001;184:904–9.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Gatteschi C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation. 1993;88:652–5.
   Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertens. 1994;24:793–801.
   PubMed Web of Science ®Google Scholar
• McGrath BP, Liang YL, Teede H, Shiel LM, Cameron JD, Dart A. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy. Arterioscler Thromb Vasc Biol. 1998;18:1149–56.
   PubMed Web of Science ®Google Scholar